Medexus Pharmaceuticals Inc. (MDP.TO)
CAD 2.76
(-1.43%)
CAD 2.76
(-1.43%)
| Breakdown | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | 18.71 Million | -1.44 Million | -1.18 Million | 5.03 Million | -1.62 Million | -1.93 Million |
| Net Income | -214 Thousand | 1.22 Million | -2.87 Million | -28.26 Million | -4.39 Million | -4.88 Million |
| Depreciation & Amortization | 5.8 Million | 6.08 Million | 6.14 Million | 5.97 Million | 3.7 Million | 1.93 Million |
| Deferred income taxes | 320 Thousand | -6.26 Million | -941 Thousand | -3.23 Million | -790.43 Thousand | -307.32 Thousand |
| Stock-based compensation | 469 Thousand | 1.21 Million | 1.88 Million | 1.27 Million | 1.47 Million | 549.67 Thousand |
| Change in working capital | 2.34 Million | -15.26 Million | 4.73 Million | 182 Thousand | -1.49 Million | 1.56 Million |
| Other non-cash items | 10.6 Million | 11.56 Million | -10.11 Million | 29.1 Million | -34.55 Thousand | -798.58 Thousand |
| Investing Cash Flow | -3.47 Million | -1.72 Million | -8.19 Million | -11.7 Million | -28.57 Million | -17.31 Million |
| Investments in PPE | -266 Thousand | -362 Thousand | -7.71 Million | -10.75 Million | -841.91 Thousand | -429.24 Thousand |
| Acquisitions | -3.21 Million | -1.35 Million | -482 Thousand | -952 Thousand | -27.93 Million | -16.88 Million |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | -216 Thousand | -406.8 Thousand | -9.52 Million | 3000.00 | 205.89 Thousand | - |
| Financing Cash Flow | -23.04 Million | 6.4 Million | 663 Thousand | 18.68 Million | 14.6 Million | 38.37 Million |
| Debt repayment | -26.4 Million | -24.72 Million | -164 Thousand | -369 Thousand | -313.77 Thousand | -5.18 Million |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | -2.63 Million | - |
| Common Stock Issuance | 7.6 Million | - | - | 22.63 Million | - | 14.98 Million |
| Other Financing Activities | -4.25 Million | 31.12 Million | 827 Thousand | -3.58 Million | 17.55 Million | 28.57 Million |
| Accounts receivables | -1.67 Million | -8.23 Million | 4.43 Million | -3.5 Million | -7.25 Million | 1.15 Million |
| Accounts payables | 11.57 Million | -5.04 Million | 4.52 Million | 6.11 Million | - | -500.85 Thousand |
| Inventory | -6.75 Million | -1.98 Million | -6.66 Million | -9000.00 | 997.03 Thousand | -80.4 Thousand |
| Other working capital | 2.95 Million | 1000.00 | 6.96 Million | 3.69 Million | 4.76 Million | 990.1 Thousand |
| Cash at beginning of period | 13.06 Million | 10.01 Million | 18.7 Million | 5.23 Million | 20.59 Million | 2.7 Million |
| Cash at end of period | 5.25 Million | 13.06 Million | 10.01 Million | 18.7 Million | 5.23 Million | 21.87 Million |
| Capital Expenditure | -266 Thousand | -362 Thousand | -7.71 Million | -10.75 Million | -841.91 Thousand | -429.24 Thousand |
| Effect of forex changes on cash | -2000.00 | -189 Thousand | 27 Thousand | 1.45 Million | 233.39 Thousand | 50.05 Thousand |
| Net cash flow / Change in cash | -7.81 Million | 3.05 Million | -8.68 Million | 13.47 Million | -15.35 Million | 19.17 Million |
| Free Cash Flow | 18.44 Million | -1.8 Million | -8.89 Million | -5.71 Million | -2.46 Million | -2.36 Million |
| Breakdown | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 | 2023 Q1 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | 1.95 Million | -214 Thousand | 762 Thousand | -534 Thousand | -1.09 Million | 651 Thousand |
| Depreciation & Amortization | 1.41 Million | 5.8 Million | 1.44 Million | 1.44 Million | 1.46 Million | 1.44 Million |
| Deferred income taxes | -57 Thousand | 320 Thousand | 228 Thousand | -261 Thousand | 120 Thousand | 233 Thousand |
| Stock-based compensation | 362 Thousand | 469 Thousand | 125 Thousand | 211 Thousand | -128 Thousand | 261 Thousand |
| Change in working capital | 2.38 Million | 2.34 Million | -1.64 Million | 3.49 Million | 2.77 Million | -2.28 Million |
| Other non-cash items | 2.03 Million | 10.6 Million | -535 Thousand | 1.17 Million | 4.21 Million | 3.91 Million |
| Investing Cash Flow | -477 Thousand | -3.47 Million | -538 Thousand | -1.75 Million | -592 Thousand | -597 Thousand |
| Investments in PPE | -32 Thousand | -266 Thousand | -218 Thousand | -4000.00 | -16 Thousand | -28 Thousand |
| Acquisitions | -445 Thousand | -3.21 Million | -320 Thousand | -1.74 Million | -576 Thousand | -569 Thousand |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | - | - | - | -0.12 | -0.16 | 0.44 |
| Financing Cash Flow | -4.49 Million | -23.04 Million | -3.96 Million | -15.15 Million | -2.96 Million | -968 Thousand |
| Debt repayment | -3.35 Million | -26.4 Million | -2.69 Million | -39.37 Million | -1.88 Million | -33 Thousand |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | 7.6 Million | -16.14 Thousand | 7.6 Million | - | - |
| Other Financing Activities | -1.13 Million | - | - | 16.61 Million | -1.08 Million | -935 Thousand |
| Accounts receivables | 10.74 Million | -1.67 Million | -1.89 Million | 484 Thousand | 3.19 Million | -3.46 Million |
| Accounts payables | - | 11.57 Million | -1.49 Million | 12.2 Million | -823.87 Thousand | 1.68 Million |
| Inventory | -5.83 Million | -6.75 Million | -2.31 Million | -2.41 Million | -14 Thousand | -2.01 Million |
| Other working capital | -2.52 Million | 2.95 Million | 4.92 Million | 5.42 Million | -407 Thousand | 3.19 Million |
| Cash at beginning of period | 5.25 Million | 13.06 Million | 8.21 Million | 19.5 Million | 15.78 Million | 13.06 Million |
| Cash at end of period | 8.45 Million | 5.25 Million | 5.25 Million | 8.21 Million | 19.5 Million | 15.78 Million |
| Capital Expenditure | -32 Thousand | -266 Thousand | -218 Thousand | -4000.00 | -16 Thousand | -28 Thousand |
| Effect of forex changes on cash | -22 Thousand | -2000.00 | -67 Thousand | 80 Thousand | -78 Thousand | 63 Thousand |
| Net cash flow / Change in cash | 3.19 Million | -7.81 Million | -2.95 Million | -11.28 Million | 3.71 Million | 2.71 Million |
| Free Cash Flow | 8.16 Million | 18.44 Million | 1.38 Million | 5.53 Million | 7.33 Million | 4.18 Million |
BIOS
ELDN
EASTW-R
023000
002382
ACUS